Peer-influenced content. Sources you trust. No registration required. This is HCN.
DermNet
Although originally described in children with hepatitis B, vaccination against this virus in most populations means EBV is now the most common association.
Dermatology April 10th 2025
GoodRx for Healthcare Professionals
Antiviral therapy initiated within 48 hours of symptom onset can reduce illness duration by 1-2 days, highlighting the importance of early recognition and intervention in high-risk populations.
Emergency Medicine January 30th 2025
Mayo Clinic Health System
Proper timing of dietary progression and recognition of warning signs remain crucial elements in managing viral gastroenteritis, particularly in vulnerable populations where complications are more common.
Emergency Medicine January 15th 2025
Recent evidence suggests a potential link between pityriasis rosea and various viral infections, including COVID-19, expanding our understanding of this common dermatological condition’s etiology.
Dermatology January 15th 2025
Epoch Health
The WHO notes significant diagnostic challenges in differentiating Lassa fever from similar viral infections due to varied and non-specific presentation.
Emergency Medicine November 11th 2024
Cleveland Clinic Journal of Medicine (CCJM)
Immunocompromised individuals are at a 6 to 11 times higher risk of developing herpes zoster compared to the general population, with hematopoietic stem cell transplant recipients facing the highest risk.
Allergy & Immunology July 18th 2024